Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats. - Wikidata - awgldk - TriplyDB

Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats.

Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats.

http://www.wikidata.org/entity/Q46847435

about

Effects of tempol and redox-cycling nitroxides in models of oxidative stress.Chemistry and antihypertensive effects of tempol and other nitroxides The adventitia: essential regulator of vascular wall structure and function DNA Damage and Pulmonary Hypertension Oxidative stress, unfolded protein response, and apoptosis in developmental toxicity Role of Uric Acid Metabolism-Related Inflammation in the Pathogenesis of Metabolic Syndrome Components Such as Atherosclerosis and Nonalcoholic Steatohepatitis Reactive oxygen species in inflammation and tissue injury Pulmonary arterial hypertension: the clinical syndrome.NOX enzymes and pulmonary disease.Oxidative stress is associated with increased pulmonary artery systolic pressure in humans.Nitric oxide and superoxide transport in a cross section of the rat outer medulla. I. Effects of low medullary oxygen tension.The role of reactive oxygen species in microvascular remodeling.Pulmonary arterial responses to reactive oxygen species are altered in newborn piglets with chronic hypoxia-induced pulmonary hypertension The role of inflammation in hypoxic pulmonary hypertension: from cellular mechanisms to clinical phenotypes.Intermittent hypoxia augments pulmonary vascular smooth muscle reactivity to NO: regulation by reactive oxygen species Xanthine oxidase-derived ROS upregulate Egr-1 via ERK1/2 in PA smooth muscle cells; model to test impact of extracellular ROS in chronic hypoxia.NADPH oxidase-derived ROS and the regulation of pulmonary vessel tone The role of pulmonary arterial stiffness in COPD.Reactive oxygen species and antioxidants in pulmonary hypertension.Superoxide dismutase mimetic, MnTE-2-PyP, attenuates chronic hypoxia-induced pulmonary hypertension, pulmonary vascular remodeling, and activation of the NALP3 inflammasome.Attenuation by statins of membrane raft-redox signaling in coronary arterial endothelium.NFAT is required for spontaneous pulmonary hypertension in superoxide dismutase 1 knockout mice.Lung EC-SOD overexpression attenuates hypoxic induction of Egr-1 and chronic hypoxic pulmonary vascular remodeling.Perinatal changes in superoxide generation in the ovine lung: Alterations associated with increased pulmonary blood flow Divergence of mechanistic pathways mediating cardiovascular aging and developmental programming of cardiovascular disease Reactive oxygen and nitrogen species in pulmonary hypertension.Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.Reactive oxygen species in pulmonary vascular remodeling.Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity.Mechanisms of intermittent hypoxia induced hypertension.Pentaerythritol Tetranitrate In Vivo Treatment Improves Oxidative Stress and Vascular Dysfunction by Suppression of Endothelin-1 Signaling in Monocrotaline-Induced Pulmonary Hypertension.Regulation of the pulmonary circulation in the fetus and newborn.Lung oxidative damage by hypoxia Reactive oxygen species as therapeutic targets in pulmonary hypertension.Hypoxic pulmonary hypertension of the newborn.Calcium homeostasis and sensitization in pulmonary arterial smooth muscle.CVD and Oxidative Stress.NADPH oxidase: its potential role in promotion of pulmonary arterial hypertension.Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension.Contribution of oxidative stress to pulmonary arterial hypertension.

P2860

Q24595411-68D4BDE2-9345-4B0F-9964-DC3D44F0629D Q24658069-43D16558-1598-4E77-B501-8C05686752B3 Q27000503-3A1A23A2-F75E-4B86-9DF7-BF304DA3BEF7 Q27005594-912F0168-481C-4760-A85A-AA969F547033 Q28084613-E8108664-388F-4575-8482-86B53755AC78 Q28354735-F6BE5712-A5D2-413E-91EB-491C2A1D911B Q28396273-5EFA096A-768E-4C9C-9F41-46ADF64D332D Q30583630-D4B467A8-DA76-4473-93EA-E1208C2F5D64 Q33649864-D77AC545-89A1-47AB-83C6-06463E67DE09 Q34068197-31BB582B-E5FC-4585-8EAA-A639CD984C98 Q34149600-D064D414-5F06-43EC-A5AA-2585FC6DFA5B Q34836065-8EDD3835-5907-403D-8114-D585173EF378 Q35091356-BBEB0B6F-8CCB-46EA-B8AC-399B475DF9D7 Q35115789-FB6A7399-11C6-433E-BBEF-41ED99F841D2 Q35325870-F211DA42-54A5-40A9-9386-4DBF090BE740 Q35576738-95210F28-DBA3-4FFD-915C-4D87F0383764 Q36042573-A599A159-52CC-4770-A253-082FC1E991A1 Q36284886-E33F05DC-555F-4BA9-B8C0-FA1691CC8B28 Q36747034-6EFBD79D-3383-4D0B-BCD8-67936F9B9044 Q36747273-5808231A-FF4C-414B-93FE-3045403374D1 Q36776589-CF7BFABE-88FE-40C7-805E-BD7FD993D919 Q36837739-FC7E7F67-7BC0-4D94-9713-0FD3C00DDEDA Q36877360-C2FDF77A-B5AA-48FC-8094-28D6D50CC67A Q37274266-A9DA68A3-8196-4E95-8079-600127772FA8 Q37284338-4A09F70B-84E8-4B71-BC38-3A621626DB17 Q37376997-AA516D9F-FB65-4680-A4DD-C14680AA1004 Q37486257-44F9DA89-1D7D-400B-8AD9-5DA461B7FAE8 Q37532988-26C3CF2D-B155-440A-A70E-1E79F856C84E Q37591231-059CF63C-E939-4E98-8783-D8AFD7EC7AD4 Q37612046-9AB561ED-E0AF-4031-A825-8ED8220391D3 Q37699822-84065003-3F62-4C5F-86A6-9A2B2E23604D Q37801516-14CCB28E-9B3C-47DB-90A7-59F5DC5E59E4 Q38042426-9EB24F19-1BF3-4FD5-B766-69A169B42308 Q38074770-2C8774DC-BC62-48B3-95B4-36E604E136B3 Q38112029-C2E6A2B9-ED59-47B4-A208-9C35EFFCC6F3 Q38151917-B19622C3-DFE2-4628-8909-7BA54F2FE75F Q38754143-E5D8355B-E280-4F64-B84E-1CE651EA8AF4 Q39132107-489A6429-FCBB-4890-B1A3-454C97479C5D Q39419466-9EEA12C3-35D9-45AB-ADE8-0CFD74036B10 Q41137411-0ADF5740-42B2-40E2-A13C-C35867DD0709

P2860

Contribution of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary hypertension in neonatal rats.

http://www.wikidata.org/entity/Q46847435

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Contribution of xanthine oxida ...... hypertension in neonatal rats.

@en

Contribution of xanthine oxida ...... hypertension in neonatal rats.

@nl

type

label

Contribution of xanthine oxida ...... hypertension in neonatal rats.

@en

Contribution of xanthine oxida ...... hypertension in neonatal rats.

@nl

prefLabel

Contribution of xanthine oxida ...... hypertension in neonatal rats.

@en

Contribution of xanthine oxida ...... hypertension in neonatal rats.

@nl

P1433

Q46847435-D3502BBD-4AC6-4C37-AADA-1FA6132F63BF

P1476

Q46847435-63392F33-86CB-404A-9550-5CE3A615F961

P2093

Q46847435-3CB850C8-EA43-47E0-967A-0766328F35C8

Q46847435-52F04E3A-9BD7-4B31-9BC7-D1E337A3F4BB

Q46847435-A732D30A-797E-4CDC-954A-77768658B3ED

Q46847435-B50F398E-81E5-492D-8540-B6FA3CD9DC33

P2860

Q46847435-0A73AA80-8519-495B-8FD7-78EE043B2C99

Q46847435-1D47A068-F315-4750-8976-4012706CABA6

Q46847435-20BEE6D3-F2B8-4141-8109-05FB5577F49A

Q46847435-28DCD93E-4FCA-4613-9288-DC9187198999

Q46847435-2E235819-9227-4756-95F4-163FED31A962

Q46847435-35998EB9-BE62-4899-A209-287F77F7458C

Q46847435-49DD1155-2709-41ED-9138-8D9BFA617F7E

Q46847435-4C807BE0-3262-495E-8CBD-4AFF2FA3E975

Q46847435-5509184D-0992-4EA9-B57A-200445758ACB

Q46847435-55197211-CEBA-4EA4-A182-6B9150C3EB2F

P304

Q46847435-882364C1-7C61-44E5-80B2-E79E2F93466C

P31

Q46847435-53BCAB28-4C90-4DA9-B28D-719D7158A3D6

P356

Q46847435-E3A51E3F-2295-4001-AB97-DE0ECDE47174

P433

Q46847435-36747290-92E6-40D7-9DE8-E6E679BA31EA

P478

Q46847435-ADF5E308-DEB7-4B04-B1DB-BE59C53FAB3D

P577

Q46847435-433F4D38-53C6-4D91-B425-827EBE404ADA

P5875

Q46847435-BE7694E8-5E35-4115-8E2A-0EC8EB5EB584

P698

Q46847435-740ECFC0-6A83-4A43-8E78-BC5E12ACF563

P921

Q46847435-E6B5AB15-F442-4003-8223-C5A8A07E67AB

P356

AJPLUNG.00166.2007

P1433

American Journal of Physiology - Lung Cellular and Molecular Physiology

P1476

Contribution of xanthine oxida ...... hypertension in neonatal rats.

@en

P2093

Crystal Kantores

http://www.w3.org/2001/XMLSchema#string

Jaques Belik

http://www.w3.org/2001/XMLSchema#string

Jingyi Pan

http://www.w3.org/2001/XMLSchema#string

Robert P Jankov

http://www.w3.org/2001/XMLSchema#string

P2860

Isoprostanes: an overview and putative roles in pulmonary pathophysiology

Endothelial nitric oxide synthase in vascular disease: from marvel to menace

Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity

Effect of the 21-aminosteroid U74389G on oxygen-induced free radical production, lipid peroxidation, and inhibition of lung growth in neonatal rats

A role for platelet-derived growth factor beta-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

Reactive oxygen species and substance P in monocrotaline-induced pulmonary hypertension.

Redox regulation of signal transduction in cardiac and smooth muscle.

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo.

P304

L233-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPLUNG.00166.2007

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

294

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5764542

http://www.w3.org/2001/XMLSchema#string

P698

18083771

http://www.w3.org/2001/XMLSchema#string

P921